Modest growth in global antibacterial drugs market, report predicts

5 October 2021
marketreportbig

The global antibacterial drugs market is projected to grow at a modest compound annual growth rate (CAGR) of 2.6% between 2021 and 2031, according to a Fact MR report.

In the short term, the market will expand at a CAGR of 1.5% from 2020 to 2025 to reach $50 billion, while by 2031 it will be worth $62 billion, the report predicts.

Historically, the market experienced sluggish growth, registering a 1% value CAGR from 2016 to 2020. At the end of this period, it was valued at around $46 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical